 | Up a level |
Journal Article
Faehling, M., Schumann, C., Christopoulos, P., Hoffknecht, P., Alt, J., Horn, M., Eisenmann, S., Schlenska-Lange, A., Aries, S. P., Sackmann, S., Schuett, P., Steger, F. and Christoph, D. (2020). Durvalumab after definitive radiochemotherapy (RCT) in locally advanced unresectable NSCLC: Real-world data on survival and safety from the German expanded access program (EAP). Ann. Oncol., 31. S. S806 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041
Griesinger, F., Buettner, R., Deppermann, K-M, Reinmuth, N., Schuette, W., Thomas, M., Wroblewski, M. and Schumann, C. (2018). Real world molecular testing in patients with EGFR mutation-positive locally advanced or advanced NSCLC in routine practice in Germany - Interim results of the clinical registry PANORAMA. Oncol. Res. Treat., 41. S. 249 - 250. BASEL: KARGER. ISSN 2296-5262
Griesinger, F., Buettner, R., Deppermann, K. -M., Reinmuth, N., Schuette, W., Thomas, M., Bergner, S. and Schumann, C. (2017). PANORAMA - Real world molecular testing, treatment patterns, and clinical outcomes in patients with EGFR mutation-positive locally advanced or advanced NSCLC. Oncol. Res. Treat., 40. S. 248 - 250. BASEL: KARGER. ISSN 2296-5262
Griesinger, F., Buettner, R., Deppermann, K. M., Reinmuth, N., Schuette, W., Thomas, M., Wroblewski, M. and Schumann, C. (2020). Real World Molecular Testing in Patients with EGFR Mutation-Positive Locally Advanced or Metastatic NSCLC in routine practice in Germany - Interim Results of the clinical registry PANORAMA. Pneumologie, 74. S. S128 - 1. STUTTGART: GEORG THIEME VERLAG KG. ISSN 1438-8790
Schumann, C., Lorenz, K. and Faust, M. (2018). Hypercalcemia. Onkologe, 24 (2). S. 151 - 163. NEW YORK: SPRINGER. ISSN 1433-0415